GlassScriptPhysician profile
Prabhat Tandon
NPI 1245265941
$5,034.07
in general payments reported to CMS, 2019-2025
46 companies · $832 in 2025
The $832 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $802 · 2020: $310 · 2021: $623 · 2022: $504 · 2023: $509 · 2024: $1,454 · 2025: $832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,155 · Travel and Lodging: $626 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,155.38 |
| Travel and Lodging | $625.74 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,201.48 | 2021-2025 | Minimed 780g |
| Novo Nordisk INC | $588.83 | 2019-2025 | Wegovy |
| Xeris Pharmaceuticals, INC. | $327.87 | 2021-2025 | Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $223.69 | 2020-2023 | |
| Beta Bionics, INC. | $205.98 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Bayer Healthcare Pharmaceuticals INC. | $203.88 | 2021-2025 | |
| Medtronic Minimed, INC. | $186.04 | 2019-2020 | |
| Amgen INC. | $183.94 | 2022-2025 | Evenity, Prolia, Tepezza |
| Abbott Laboratories | $154.98 | 2019-2024 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.68 | 2023-2025 | Jardiance, Tradjenta |
| Corcept Therapeutics | $131.41 | 2019-2025 | Korlym |
| Avinger INC. | $120.23 | 2019 | |
| Valeritas, INC. | $108.49 | 2019 | |
| Radius Health, INC. | $102.07 | 2019-2022 | |
| Shockwave Medical, INC | $81.65 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prabhat Tandon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.